X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5186) 5186
female (3609) 3609
surgery (3604) 3604
male (3479) 3479
middle aged (3344) 3344
oncology (3325) 3325
aged (3102) 3102
cancer (2740) 2740
chemotherapy (2312) 2312
adult (2256) 2256
chemoradiotherapy (2047) 2047
treatment outcome (1955) 1955
radiotherapy (1949) 1949
neoadjuvant therapy (1891) 1891
neoplasm staging (1867) 1867
rectal cancer (1810) 1810
preoperative chemoradiotherapy (1681) 1681
rectal neoplasms - pathology (1624) 1624
survival (1563) 1563
prognosis (1561) 1561
colorectal cancer (1490) 1490
aged, 80 and over (1396) 1396
care and treatment (1389) 1389
rectal neoplasms - therapy (1370) 1370
preoperative radiotherapy (1332) 1332
retrospective studies (1321) 1321
carcinoma (1302) 1302
combined modality therapy (1209) 1209
chemoradiation (1188) 1188
total mesorectal excision (1163) 1163
gastroenterology & hepatology (1141) 1141
medicine & public health (1120) 1120
rectal neoplasms - surgery (1000) 1000
radiation-therapy (992) 992
antineoplastic combined chemotherapy protocols - therapeutic use (974) 974
adenocarcinoma (955) 955
therapy (926) 926
preoperative care (924) 924
disease-free survival (897) 897
analysis (870) 870
survival rate (870) 870
radiology, nuclear medicine & medical imaging (869) 869
esophageal cancer (860) 860
preoperative chemoradiation (857) 857
adenocarcinoma - therapy (813) 813
rectal neoplasms - radiotherapy (782) 782
adenocarcinoma - pathology (763) 763
chemotherapy, adjuvant (723) 723
colorectal-cancer (723) 723
research (722) 722
follow-up studies (714) 714
tumors (666) 666
randomized-trial (642) 642
neoadjuvant chemoradiotherapy (624) 624
patients (615) 615
squamous-cell carcinoma (609) 609
radiation (608) 608
health aspects (606) 606
trial (601) 601
preoperative chemotherapy (600) 600
rectal neoplasms - drug therapy (599) 599
adjuvant treatment (589) 589
esophageal neoplasms - therapy (587) 587
radiotherapy, adjuvant (587) 587
prospective studies (585) 585
survival analysis (584) 584
rectal neoplasms - mortality (583) 583
metastasis (575) 575
fluorouracil - administration & dosage (574) 574
resection (565) 565
radiation therapy (561) 561
hematology, oncology and palliative medicine (560) 560
postoperative chemoradiotherapy (541) 541
adenocarcinoma - surgery (522) 522
esophageal neoplasms - pathology (510) 510
phase-iii trial (483) 483
neoadjuvant therapy - methods (474) 474
rectum (473) 473
risk factors (472) 472
abridged index medicus (470) 470
recurrence (470) 470
fluorouracil (469) 469
magnetic resonance imaging (467) 467
surgical oncology (467) 467
lymphatic metastasis (463) 463
adjuvant chemotherapy (461) 461
cancer therapies (457) 457
pathological complete response (451) 451
adenocarcinoma - mortality (439) 439
local recurrence (438) 438
neoadjuvant chemotherapy (437) 437
oncology, experimental (418) 418
gastroenterology (416) 416
cancer patients (415) 415
chemoradiotherapy, adjuvant (411) 411
multivariate analysis (398) 398
esophageal neoplasms - surgery (394) 394
patient outcomes (389) 389
oxaliplatin (388) 388
esophageal neoplasms - mortality (384) 384
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6511) 6511
German (89) 89
French (68) 68
Japanese (59) 59
Spanish (17) 17
Chinese (14) 14
Korean (5) 5
Russian (5) 5
Czech (3) 3
Italian (3) 3
Portuguese (3) 3
Turkish (3) 3
Polish (2) 2
Bulgarian (1) 1
Dutch (1) 1
Hungarian (1) 1
Icelandic (1) 1
Lithuanian (1) 1
Norwegian (1) 1
Persian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 2012, Volume 366, Issue 22, pp. 2074 - 2084
Journal Article
International journal of radiation oncology, biology, physics, ISSN 0360-3016, 2011, Volume 81, Issue 3, pp. 684 - 690
Purpose In this Phase II study, we evaluated the efficacy and toxicity of chemoradiotherapy (CRT) with cisplatin (CDDP... 
Radiology | Hematology, Oncology and Palliative Medicine | Esophageal squamous cell carcinoma | Long-term toxicity | Salvage surgery | Chemoradiotherapy | SURGERY | SURVIVAL | CANCER | CHEMOTHERAPY | SALVAGE ESOPHAGECTOMY | RADIATION-THERAPY | ONCOLOGY | CHEMORADIATION | RADIOTHERAPY | DEFINITIVE CHEMORADIOTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Chemoradiotherapy - adverse effects | Age Factors | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Cisplatin - administration & dosage | Esophageal Neoplasms - pathology | Carcinoma, Squamous Cell - mortality | Fluorouracil - administration & dosage | Esophageal Neoplasms - mortality | Adult | Female | Surveys and Questionnaires | Esophageal Neoplasms - therapy | Radiotherapy Dosage | Chemoradiotherapy - methods | Drug Administration Schedule | Carcinoma, Squamous Cell - therapy | Survival Rate | Remission Induction | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Health Status | Neoplasm Staging | Salvage Therapy - methods | Preoperative Care - methods | Medical colleges | Chemotherapy | Squamous cell carcinoma | Information services | Clinical trials | Esophageal cancer | Information services industry | Cisplatin | Cancer | Fluorouracil | Index Medicus | ESOPHAGUS | DIGESTIVE SYSTEM | COMPLEXES | HETEROCYCLIC COMPOUNDS | DEATH | INFUSION | MEDICINE | AZINES | ANTIMETABOLITES | FLUOROURACILS | IRRADIATION | ORGANIC HALOGEN COMPOUNDS | HYDROXY COMPOUNDS | THERAPY | DRUGS | RADIOLOGY AND NUCLEAR MEDICINE | PNEUMONITIS | ORGANIC NITROGEN COMPOUNDS | COMBINED THERAPY | RADIOLOGY | URACILS | NEOPLASMS | ORGANIC COMPOUNDS | ORGANIC FLUORINE COMPOUNDS | INTAKE | PYRIMIDINES | TOXICITY | SYMPTOMS | TRANSITION ELEMENT COMPLEXES | PLATINUM COMPLEXES | NUCLEAR MEDICINE | ORGANS | SURVIVAL TIME | DISEASES | CARCINOMAS | NAUSEA | BODY
Journal Article
Journal Article
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2010, Volume 28, Issue 5, pp. 859 - 865
Journal Article
Best Practice & Research: Clinical Gastroenterology, ISSN 1521-6918, 2016, Volume 30, Issue 4, pp. 617 - 628
.... When fractionated conventionally it should be given as chemoradiotherapy. Recently, stereotactic body radiotherapy emerged as an alternative, but will have to be carefully investigated in clinical trials... 
Gastroenterology and Hepatology | Chemoradiotherapy | Chemotherapy | Pancreatic cancer | MITOMYCIN-C | ADENOCARCINOMA | PHASE-II | RANDOMIZED CONTROLLED-TRIAL | GEMCITABINE | RADIATION-THERAPY | PREOPERATIVE THERAPY | ADJUVANT RADIATION | TARGET VOLUME | GASTROENTEROLOGY & HEPATOLOGY | COOPERATIVE-ONCOLOGY-GROUP | Induction Chemotherapy | Chemoradiotherapy - methods | Humans | Pancreatic Neoplasms - therapy | Cancer
Journal Article